Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2020

Published	Pages	Publisher	Report code
Sep 2020	56	Global Markets Direct	ASDR-565141

Published: Sep 2020 - Pages : 56 - Publisher : Global Markets Direct - Report code : ASDR-565141

Better Life Pharmaceuticals Inc
Dare Bioscience Inc
Emotional Brain BV
EndoCeutics Inc
Fabre-Kramer Pharmaceuticals Inc
Ivix Ltd
Kuhnil Pharmaceutical Co Ltd
S1 Biopharma Inc

Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

Published: May, 2022 | Report code: ASDR-601516